<DOC>
	<DOCNO>NCT01487486</DOCNO>
	<brief_summary>To best investigator knowledge , exhaustive characterization low high abundant protein glyco-proteins Follicular Fluid ( FF ) yet achieve . Such analysis may provide critical molecular data role FF oocyte maturation may identify specific change FF proteome patient gynecologic problem , Polycystic Ovary Syndrome ( PCOS ) . Specific Aims 1 . To perform comprehensive analysis normal human FF use sensitive mass spectrometry combination conventional approach proteomic evaluation use HPLC Western blot glyco-proteomic analysis . 2 . Characterize differential proteomic glyco-proteomic pattern FF normal woman compare lean obese woman PCOS . 3 . To supplement differential proteomic glyco-proteomic analysis steroid hormone analysis FF sample .</brief_summary>
	<brief_title>Proteomics &amp; Glyco-Proteomic Analysis Follicular Fluid</brief_title>
	<detailed_description>In study , plan utilize ultrasensitive mass spectrometry ( MS ) conventional proteomic approach identify low high abundant protein present human FF . Additionally , plan use high-performance liquid chromatography ( HPLC ) Western blot technique evaluate Neu5Gc glycan array base ELISA technique detect anti-Neu5Gc antibody profile human FF . This analysis perform FF sample obtain normal woman undergo In-Vitro Fertilization Embryo Transfers ( IVF-ET ) male factor alone oocyte donor 3rd Party Reproduction Program lean obese woman PCOS . This study provide information protein , glycoprotein , steroid hormone expression normal folliculogenesis pathologic condition PCOS , also provide basic scientific information normal abnormal oocyte development . Human FF bath develop oocyte . Previous study indicate FF contains cytokine , steroidal protein hormone , growth factor . The presence proteins significant biological property implies paracrine autocrine role FF promote normal oocyte development . Furthermore , presence antigenic sialic acid Neu5Gc presence antibody target antigenic glycoconjugates ( glycolipid glycoprotein decorate sialic acid ) may interfere oocyte development , hormonal expression , fertilization , possibly implantation . Here hypothesize exhaustive proteomic glyco-proteomic characterization human FF essential thorough understanding biological significance . We also hypothesize PCOS may differential expression FF protein glyco-protein milieu , expression may differ lean obese woman PCOS . PCOS represent heterogeneous disorder . The severity hyperandrogensim , metabolic menstrual disturbance , obesity variable 40 % clinically express sign classic hyperandrogenism . On hand , atypical , often lean , PCOS woman impair glucose tolerance diabetes . Reports suggest lean PCOS woman alter serum IGFBP-1 , characteristic endocrine feature patient obese PCOS , related hyperinsulinemia and/or obesity . The lean phenotype PCOS significance unclear may represent cryptic unexpressed form PCOS may prelude individual later manifest clinical sign obese/overweight PCOS . Changes expression may expect different amount steroidal hormone inflammatory marker FF derive woman PCOS .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>Inclusion criterion : Inclusion Criteria All 1 . Female patient undergo controlled ovarian hyperstimulation ( COH ) , transvaginal oocyte aspiration ( TVA ) , Saline Infused Sonography ( SIS ) UL collection 2 . Age &lt; 35 y/o time vitro fertilization ( IVF ) cycle 3 . Normal ovarian function define Day 3 Follicular Stimulating Hormone ( FSH ) &lt; 8 pg/ml AntiMullerian Hormone ( ≥ 1.0 ng/ml ) Inclusion Criteria Controls : 1 . Female patient undergo COH TVA donate oocyte 2 . Female patient undergo COH TVA male factor infertility ( i.e . female cause infertility ) 3 . Normal menstrual cycle Inclusion Criteria Lean PCOS : 1 . Diagnosis PCOS Rotterdam Criteria 2 . BMI ≤ 25 kg/m2 Inclusion Criteria Classic PCOS 1 . Diagnosis PCOS Rotterdam Criteria 2 . BMI &gt; 30 kg/m2 Exclusion criterion : 1 . Age ≥ 35 y/o 2 . Female partner infertility associate diagnosis ( i.e . tubal factor , cervical factor , endometriosis ) 3 . Unexplained infertility</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Polycystic Ovary Syndrome</keyword>
	<keyword>PCOS</keyword>
	<keyword>Follicular Fluid</keyword>
	<keyword>Proteomics</keyword>
	<keyword>Glyco-proteomics</keyword>
</DOC>